Clinical Trials Browser

Has results × Neoplasm Metastasis × nilotinib × Clear all

NCT01089595 2017-03-15

Trial of Tasigna (Nilotinib) 400 mg Twice Daily Alone or With Gleevec (Imatinib Mesylate) 400 mg Daily for Patients With Advanced Gastrointestinal Stromal Tumor (GIST)

Phase 2 Terminated

5 enrolled 8 charts

Neoplasm Metastasis